159 related articles for article (PubMed ID: 32048744)
21. Fibrous papule of the face with granular cells.
Jacyk WK; Rütten A; Requena L
Dermatology; 2008; 216(1):56-9. PubMed ID: 18032900
[TBL] [Abstract][Full Text] [Related]
22. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
[TBL] [Abstract][Full Text] [Related]
24. Case for diagnosis. Lichen myxedematosus.
Rebellato PR; Carbonar MB; Tabuti NI; Rastelli GJ
An Bras Dermatol; 2016; 91(6):842-843. PubMed ID: 28099617
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases.
Rongioletti F; Merlo G; Carli C; Cribier B; Metze D; Calonje E; Kempf W; Stefanato CM; Marinho E; Kanitakis J
J Am Acad Dermatol; 2016 Jun; 74(6):1194-200. PubMed ID: 26897387
[TBL] [Abstract][Full Text] [Related]
26. Scleromyxoedema in a dog.
Laprais AF; Bizikova P; Lashnits EW; Tucker A; Linder KE
Vet Dermatol; 2017 Oct; 28(5):503-e119. PubMed ID: 28439995
[TBL] [Abstract][Full Text] [Related]
27. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
[TBL] [Abstract][Full Text] [Related]
28. Scleromyxedema and lichen myxedematosus: Is it associated with viral hepatitis?
Chen KY; Tzeng IS; Lee YY; Ting SW; Chang YY; Ng CY
J Dermatol; 2019 Oct; 46(10):879-885. PubMed ID: 31461182
[TBL] [Abstract][Full Text] [Related]
29. [Atypical scleromyxedema with a granulomatous histological pattern and delayed sclerosis].
de Cambourg G; Goussot R; Wettlé C; Cribier B
Ann Dermatol Venereol; 2016 May; 143(5):382-6. PubMed ID: 26969478
[TBL] [Abstract][Full Text] [Related]
30. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
31. [Is scleromyxedema a skin problem or systemic pathological process?].
Radenska-Lopovok SG; Volkova P
Arkh Patol; 2018; 80(1):63-66. PubMed ID: 29460897
[TBL] [Abstract][Full Text] [Related]
32. Scleromyxedema.
Cokonis Georgakis CD; Falasca G; Georgakis A; Heymann WR
Clin Dermatol; 2006; 24(6):493-7. PubMed ID: 17113967
[TBL] [Abstract][Full Text] [Related]
33. Scleromyxedema: clinical diagnosis and autopsy findings.
Sala AC; Cunha PR; Pinto CA; Alves CA; Paiva IB; Araujo AP
An Bras Dermatol; 2016; 91(5 suppl 1):48-50. PubMed ID: 28300892
[TBL] [Abstract][Full Text] [Related]
34. Scleromyxoedema with disseminated subcutaneous nodules: rare presentation of an uncommon dermatosis.
Singh S; Kanwar AJ; Saikia UN
Clin Exp Dermatol; 2013 Jan; 38(1):36-9. PubMed ID: 22607617
[TBL] [Abstract][Full Text] [Related]
35. Diffuse papules and skin tightening.
Park JK; Lee JS; Song YW; Lee EB
Arthritis Rheumatol; 2014 May; 66(5):1326. PubMed ID: 24782190
[No Abstract] [Full Text] [Related]
36. Rhinophyma's fibrous variant. Histopathology and immunohistochemistry.
Tope WD; Sangueza OP
Am J Dermatopathol; 1994 Jun; 16(3):307-10. PubMed ID: 7943640
[TBL] [Abstract][Full Text] [Related]
37. Clinical and histopathological evaluation of cutaneous angiofibromas.
Nasimi M; Kamyab K; Moradi A; Dasdar S; Kianfar N
J Cutan Pathol; 2021 Oct; 48(10):1262-1265. PubMed ID: 33977570
[TBL] [Abstract][Full Text] [Related]
38. Nodular-Type Lichen Myxedematosus: A Rare Variant With Exclusive Involvement of the Hands-Report of Two Cases With a Comprehensive Review of the Literature.
Cerroni L; Rongioletti F
Am J Dermatopathol; 2024 Jan; 46(1):36-39. PubMed ID: 37982501
[TBL] [Abstract][Full Text] [Related]
39. [Scleromyxedema].
Sunderkötter C; Bruns T; Pfeiffer C
Dermatologie (Heidelb); 2024 Mar; 75(3):225-231. PubMed ID: 38363313
[TBL] [Abstract][Full Text] [Related]
40. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].
Topf S; Simon M; Schell H; Lüftl M
Hautarzt; 2007 Jun; 58(6):525-8. PubMed ID: 17165069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
